Synaptive Medical

Synaptive Medical announced that it launched the next generation of its robotic exoscope — the fourth-generation Modus X.

Toronto-based Synaptive Medical designed Modus X with 4K 3D optics, 27-times magnification, automated image focus, voice guidance and more. The platform enables fluorescence-guided surgery to improve oncological tissue differentiation in real time.

Additionally, Modus X’s flexible design allows for field upgrades of Modus V, the previous-generation exoscope. Synaptive said in a news release that 80 hospitals worldwide have the Modus V system installed.

Modus X joins the Synaptive integrated suite of products connecting clinicians in operating rooms. It spans mid-field MRI, surgical planning and navigation, plus surgical visualization. The company says it designed its services to automate critical patient data through every step of surgical intervention. This improves clinical decision-making.

“We anticipate these enhanced…

Synaptive Medical this week said it appointed Marc Buntaine as CEO.

Buntaine has more than 25 years of experience in the medical equipment industry. Prior to joining the company, he was executive VP of sales and marketing at Mobius Imaging, which was later acquired by Stryker. He was also the cofounder of Mevion Medical Systems and Surgical Navigation Technologies, which was later sold to Medtronic.

“We are delighted to welcome Marc during this exciting time of growth at Synaptive,” president and cofounder Cameron Piron said in a news release. “Marc brings to the company an impressive background with nearly 30 years experience in launching and marketing neurosurgery products. With Marc’s expertise, I believe we will be able to further extend the capabilities and access of our robotically controlled surgical equipment and diagnostics.”

Buntaine has also held a number of leadership roles at Elekta, Bain and Company and Cummins Engine Company.

“I am …